Mid-market private equity firm Multiples Alternate Asset Management Pvt. Ltd has reached the first close of its third fund, while Actis Advisers Pvt. Ltd is in final talks with a consortium of private equity investors to sell its stake in Symbiotec Pharmalab.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
